Reports of the death of dental cavities are greatly exaggerated

Role of S. mutans and citation quality

• Several comments dissect the article’s citation trail about S. mutans being “<2% of bacteria that cause caries.”
• They note a slide from “implicated in caries” → “cause caries” → mere prevalence in plaque/lesions.
• This is used to argue the article overstates how little S. mutans matters, even though other acid-producing species clearly play important roles.

Lumina/BCS3-L1: efficacy vs risk

• Some see Lumina as potentially valuable even if it only partially reduces cavities; non‑perfect benefit could still be meaningful at scale.
• Others argue the article ignores partial benefit and is too dismissive, focusing on “not a cure” rather than “how much reduction.”
• Major safety concerns raised from the thread and article:
  • Engineered strain can form persistent biofilms and may be hard to eradicate.
  • Potential to acquire pathogenic genes laterally and become harmful.
  • Possible suppression of beneficial oral microbiota.
  • No clear “kill switch” and unknown long‑term systemic effects (e.g., if colonizing the gut, theoretical links like auto‑brewery syndrome).
• Critics of Lumina stress that even its intended mechanism may not substantially reduce caries if many other bacteria fill the same niche.

Regulation, FDA, and Prospera

• One camp blames FDA requirements (especially quarantine and containment) for making human trials effectively impossible, thus stalling innovation.
• Others respond that, because the bacteria could spread beyond volunteers, strict controls are appropriate—analogous to containing other transmissible agents.
• Debate over whether regulators are too biased toward avoiding visible harm vs enabling progress.
• Some point out Lumina is now being sold in a lightly regulated jurisdiction (Próspera), which others see as a red flag rather than a feature.

Alternatives: fluoride, probiotics, hygiene, and folk methods

• Multiple comments emphasize that conventional oral hygiene (brushing with fluoride toothpaste, flossing/interdental cleaning, diet control) remains the best‑supported strategy.
• There’s discussion of:
  • Fluoride’s effectiveness and concerns about water fluoridation vs topical use.
  • Alternative products (e.g., hydroxyapatite/Novamin toothpastes, S. salivarius M18 probiotics) with varying levels of supporting evidence.
  • Oil pulling and vitamin K2, generally viewed skeptically or as anecdotal.
  • Flossing evidence: some note weak high‑quality data; others cite institutional recommendations.

Genetics, lifestyle, and variability

• Many anecdotes highlight large individual differences in cavity susceptibility despite similar hygiene and diet, suggesting genetics, microbiome composition, early‑life conditions, and other factors play substantial roles beyond behavior alone.